Abicipar Pegol Phase 3 AMD Studies

Related

• 

  Episode 1: Review of the Clarity Study with Dr. Amin Kherani

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2017

• 

  Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study

  David S. Boyer, MD

  Updates from the Field

  2021

• 

  Episode 2: Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration with Dr. Brian Ballio

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2017